
-
Millions of children to suffer from Trump aid cuts
-
Veteran Wallaby Beale set for long-awaited injury return
-
Syria's Druze take up arms to defend their town against Islamists
-
Tesla sales plunge further in France, down 59% in April
-
US calls on India and Pakistan to 'de-escalate'
-
Israel reopens key roads as firefighters battle blaze
-
Europe far-right surge masks divisions
-
James will mull NBA future after Lakers playoff exit
-
Ukraine's chief rabbi sings plea to Trump to side with Kyiv
-
Australian mushroom meal victim 'hunched' in pain, court hears
-
Lakers dumped out of playoffs by Wolves, Rockets rout Warriors
-
Booming tourism and climate change threaten Albania's coast
-
US reaching out to China for tariff talks: Beijing state media
-
Tariffs prompt Bank of Japan to lower growth forecasts
-
Kiss faces little time to set Wallabies on path to home World Cup glory
-
Serbian students, unions join forces for anti-corruption protest
-
Slow and easily beaten -- Messi's Miami project risks global embarrassment
-
Fan in hospital after falling to field at Pirates game
-
Nuclear power sparks Australian election battle
-
Tokyo stocks rise as BoJ holds rates steady
-
Bank of Japan holds rates, lowers growth forecasts
-
'Sleeping giants' Bordeaux-Begles awaken before Champions Cup semis
-
Napoli eye Scudetto as Inter hope for post-Barca bounce-back
-
Germany's 'absolutely insane' second tier rivalling Europe's best
-
PSG minds on Arsenal return as French clubs scrap for Champions League places
-
UK WWII veteran remembers joy of war's end, 80 years on
-
Myanmar junta lets post-quake truce expire
-
Rockets romp past Warriors to extend NBA playoff series
-
Messi, Inter Miami CONCACAF Cup dream over as Vancouver advance
-
UN body warns over Trump's deep-sea mining order
-
UK local elections test big two parties
-
US judge says Apple defied order in App Store case
-
Seventeen years later, Brood XIV cicadas emerge in US
-
Scorching 1,500m return for Olympic great Ledecky in Florida
-
Israel's Netanyahu warns wildfires could reach Jerusalem
-
Istanbul lockdown aims to prevent May Day marches
-
Formation Metals Announces Appointment of Adrian Smith to Advisory Committee
-
Cerrado Gold Announces Q4 And Annual 2024 Financial Results
-
Australian guard Daniels of Hawks named NBA's most improved
-
Mexico City to host F1 races until 2028
-
Morales vows no surrender in bid to reclaim Bolivian presidency
-
Ukraine, US sign minerals deal, tying Trump to Kyiv
-
Phenomenons like Yamal born every 50 years: Inter's Inzaghi
-
Ukraine, US say minerals deal ready as Kyiv hails sharing
-
Global stocks mostly rise following mixed economic data
-
O'Sullivan says he must play better to win eighth snooker world title after seeing off Si Jiahui
-
Sabalenka eases past Kostyuk into Madrid Open semis
-
Netflix's 'The Eternaut' echoes fight against tyranny: actor Ricardo Darin
-
US economy unexpectedly shrinks, Trump blames Biden
-
Barca fight back against Inter in sensational semi-final draw

'Blessed': US woman sees second chance in life after pig kidney transplant
Towana Looney donated a kidney to her mother in 1999 only for the remaining one to fail several years later due to pregnancy complications.
Now, the 53-year-old from Alabama has become the latest recipient of a gene-edited pig kidney -- and is currently the only living person in the world with an animal organ transplant, New York's NYU Langone hospital announced Tuesday.
"I'm overjoyed, I'm blessed to have received this gift, this second chance at life," Looney said during a press conference, held three weeks after the procedure.
Xenotransplantation, the process of transplanting organs from one species to another, has long been a tantalizing yet elusive scientific goal. Early experiments on primates faltered. But recent advances in gene editing and immune system management have brought the dream closer to reality.
Pigs have emerged as the ideal donors: they grow quickly, produce large litters and are already part of the human food supply.
Advocates hope this approach can help address the severe organ shortage in the United States, where more than 100,000 people are waiting for transplants, including over 90,000 in need of kidneys.
- A last chance -
Looney had been living with dialysis since December 2016 -- eight grueling years. High blood pressure caused by preeclampsia had taken its toll, leaving her with chronic kidney disease.
Despite receiving priority on transplant waiting lists as a living donor, her search for a compatible kidney was a frustrating dead end. Her unusually high levels of harmful antibodies made rejection almost inevitable, and as her body lost viable blood vessels to support dialysis, her health declined.
Out of options, Looney applied to join a clinical trial for pig kidney transplants, and finally underwent the seven-hour surgery on November 25.
Asked how she felt afterward, Looney's joy was infectious. "I'm full of energy, I've got an appetite... and of course, I can go to the bathroom. I haven't been going in eight years!" she laughed, adding that she was looking forward to celebrating at Disney World.
Jayme Locke, a surgeon on the transplant team, described the results with awe. "The kidney functioned essentially exactly like a kidney from a living donor," she said, adding that Looney's husband saw a rosiness in her cheeks for the first time in years.
"That is the miracle of transplantation."
- Cautious optimism -
Looney's surgery is the third time a gene-edited pig kidney has been transplanted into a human who is not brain dead.
Rick Slayman, the first recipient, died in May, two months after his procedure at Massachusetts General Hospital. The second, Lisa Pisano, initially showed signs of recovery following her surgery at NYU Langone, but the organ had to be removed after 47 days, and she passed away in July.
Looney, however, was not terminally ill before the transplant, noted Robert Montgomery, who led the surgery. He said each case offers valuable lessons, helping teams refine their techniques.
The kidney was provided by biotech company Revivicor, which breeds pigs with genetically modified kidneys less likely to be rejected by patients' immune systems.
It features 10 genetic edits to enhance compatibility with the human body -- an advance over earlier efforts that used kidneys with a single gene edit and included the pig's thymus gland to help train the host's immune system and prevent rejection.
Both methods are expected to undergo clinical trials "probably by this time next year, or even sooner," Montgomery added.
A pioneer in the field, Montgomery performed the first gene-edited pig organ transplant into a neurologically deceased patient in 2021. Looney's surgery marks his seventh human xenotransplantation.
Looney was discharged December 6 to a nearby New York City apartment. Though her high antibody levels remain a concern, doctors are monitoring her closely using wearable technology and are trying a novel drug regimen to prevent rejection.
Periodic hospital visits may still be required, but the team remains optimistic she can return home in three months.
Ch.Kahalev--AMWN